WKN: | A1W1KK |
ISIN: | US23282W6057 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Cytokinetics-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 17. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2021 | 16,70 | 40,60 | 143,11% |
2 | 2020 | 9,05 | 16,70 | 84,53% |
3 | 2023 | 42,00 | 74,00 | 76,19% |
4 | 2015 | 5,64 | 9,56 | 69,50% |
5 | 2019 | 5,36 | 9,05 | 68,84% |
6 | 2013 | 3,00 | 4,80 | 60,00% |
7 | 2016 | 9,56 | 11,84 | 23,85% |
8 | 2014 | 4,80 | 5,64 | 17,50% |
9 | 2009 | 10,38 | 11,22 | 8,09% |
10 | 2022 | 40,60 | 42,00 | 3,45% |
11 | 2006 | 33,30 | 32,22 | -3,24% |
12 | 2025 | 44,80 | 41,80 | -6,70% |
13 | 2010 | 11,22 | 9,06 | -19,25% |
14 | 2018 | 6,95 | 5,36 | -22,88% |
15 | 2012 | 4,42 | 3,00 | -32,13% |
16 | 2007 | 32,22 | 20,34 | -36,87% |
17 | 2024 | 74,00 | 44,80 | -39,46% |
18 | 2017 | 11,84 | 6,95 | -41,30% |
19 | 2008 | 20,34 | 10,38 | -48,97% |
20 | 2011 | 9,06 | 4,42 | -51,21% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2011 | 9,06 | 4,42 | -51,21% |
2 | 2008 | 20,34 | 10,38 | -48,97% |
3 | 2017 | 11,84 | 6,95 | -41,30% |
4 | 2024 | 74,00 | 44,80 | -39,46% |
5 | 2007 | 32,22 | 20,34 | -36,87% |
6 | 2012 | 4,42 | 3,00 | -32,13% |
7 | 2018 | 6,95 | 5,36 | -22,88% |
8 | 2010 | 11,22 | 9,06 | -19,25% |
9 | 2025 | 44,80 | 41,80 | -6,70% |
10 | 2006 | 33,30 | 32,22 | -3,24% |
11 | 2022 | 40,60 | 42,00 | 3,45% |
12 | 2009 | 10,38 | 11,22 | 8,09% |
13 | 2014 | 4,80 | 5,64 | 17,50% |
14 | 2016 | 9,56 | 11,84 | 23,85% |
15 | 2013 | 3,00 | 4,80 | 60,00% |
16 | 2019 | 5,36 | 9,05 | 68,84% |
17 | 2015 | 5,64 | 9,56 | 69,50% |
18 | 2023 | 42,00 | 74,00 | 76,19% |
19 | 2020 | 9,05 | 16,70 | 84,53% |
20 | 2021 | 16,70 | 40,60 | 143,11% |